Clinical Trial Update: A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BI 1467335 in diabetic retinopathy completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• BI 1467335 (BI 1467335)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2021-06-04